
|Articles|April 15, 2016
Biosimilar Cost Questions Highlight Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top news of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/biosimilar-cost-questions-highlight-specialty-phar" target="_blank">View the story "Biosimilar Cost Questions Highlight Specialty Pharmacy Week in Review" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
CMS Announces 15 Drugs for Third Cycle of Medicare Drug Price Negotiation Program
2
Dextromethorphan Emerges as a Novel Antidepressant Pathway for Treatment-Resistant Depression
3
New 2025 Hypertension Management Guidelines Include Key Updates
4
Q&A: Why Dry January and GLP-1 Therapy May Be a Turning Point for Metabolic Health
5


















